EUVIMEDTutustu EUVIMEDiin
Open access · CC BY 4.0

2022 Update of the Consensus on the Rational Use of Antithrombotics and Thrombolytics in Veterinary Critical Care (CURATIVE) Domain 6: Defining rational use of thrombolytics

Claire R Sharp, Marie-Claude Blais, Corrin J Boyd, Benjamin M Brainard, Daniel L Chan, Armelle de Laforcade, Robert Goggs, Julien Guillaumin, Alex Lynch, Erin Mays, Duana McBride, Tommaso Rosati and 1 more

Journal of Veterinary Emergency and Critical Care · 2022-07 · 32 (4) · 446-470

DOI: 10.1111/vec.13227 ↗

At a glance

Journal article in Journal of Veterinary Emergency and Critical Care, published online on 2022-07-26. Written by Claire R Sharp and 12 co-authors. Institution: School of Veterinary Medicine, Murdoch University, Murdoch, Western Australia, Australia. Major MEDLINE topics: Cat Diseases, Dog Diseases, Venous Thrombosis. Cited 18 times so far (Crossref); 146 references. The full text is freely available (open access, CC BY 4.0).

TiivistelmäSubjectsBibliografiset tiedotCiteRelated studies

Abstract (original language)

Objectives

To systematically review available evidence and establish guidelines related to the use of thrombolytics for the management of small animals with suspected or confirmed thrombosis.

Design

PICO (Population, Intervention, Control, and Outcome) questions were formulated, and worksheets completed as part of a standardized and systematic literature evaluation. The population of interest included dogs and cats (considered separately) and arterial and venous thrombosis. The interventions assessed were the use of thrombolytics, compared to no thrombolytics, with or without anticoagulants or antiplatelet agents. Specific protocols for recombinant tissue plasminogen activator were also evaluated. Outcomes assessed included efficacy and safety. Relevant articles were categorized according to level of evidence, quality, and as to whether they supported, were neutral to, or opposed the PICO questions. Conclusions from the PICO worksheets were used to draft guidelines, which were subsequently refined via Delphi surveys undertaken by the Consensus on the Rational Use of Antithrombotics and Thrombolytics in Veterinary Critical Care (CURATIVE) working group.

Results

Fourteen PICO questions were developed, generating 14 guidelines. The majority of the literature addressing the PICO questions in dogs is experimental studies (level of evidence 3), thus providing insufficient evidence to determine if thrombolysis improves patient‐centered outcomes. In cats, literature was more limited and often neutral to the PICO questions, precluding strong evidence‐based recommendations for thrombolytic use. Rather, for both species, suggestions are made regarding considerations for when thrombolytic drugs may be considered, the combination of thrombolytics with anticoagulant or antiplatelet drugs, and the choice of thrombolytic agent.

Conclusions

Substantial additional research is needed to address the role of thrombolytics for the treatment of arterial and venous thrombosis in dogs and cats. Clinical trials with patient‐centered outcomes will be most valuable for addressing knowledge gaps in the field.

Subjects

MeSH terms (MEDLINE)

Cat DiseasesDog DiseasesVenous ThrombosisAnimalsAnticoagulantsCatsCritical CareDogsFibrinolytic AgentsTissue Plasminogen Activator

Author keywords

anticoagulantantiplatelet agentcatsdogsthrombosis

Substances

AnticoagulantsFibrinolytic AgentsTissue Plasminogen Activator

Authors and institutions

  • School of Veterinary Medicine, Murdoch University, Murdoch, Western Australia, Australia.
  • Department of Clinical Sciences, University of Montreal, Saint-Hyacinthe, Quebec, Canada.
  • Department of Small Animal Medicine and Surgery, College of Veterinary Medicine, University of Georgia, Athens, Georgia, USA.
  • Department of Clinical Science and Services, The Royal Veterinary College, London, UK.
  • Department of Clinical Sciences, Cummings School of Veterinary Medicine, Tufts University, North Grafton, Massachusetts, USA.
  • Department of Clinical Sciences, Cornell University College of Veterinary Medicine, Ithaca, New York, USA.

Cite

APA

Sharp, C. R., Blais, M. C., Boyd, C. J., Brainard, B. M., Chan, D. L., de Laforcade, A., Goggs, R., Guillaumin, J., Lynch, A., Mays, E., McBride, D., Rosati, T., & Rozanski, E. A. (2022). 2022 Update of the Consensus on the Rational Use of Antithrombotics and Thrombolytics in Veterinary Critical Care (CURATIVE) Domain 6: Defining rational use of thrombolytics. Journal of Veterinary Emergency and Critical Care, 32(4), 446-470. https://doi.org/10.1111/vec.13227

Vancouver

Sharp CR, Blais MC, Boyd CJ, Brainard BM, Chan DL, de Laforcade A, et al. 2022 Update of the Consensus on the Rational Use of Antithrombotics and Thrombolytics in Veterinary Critical Care (CURATIVE) Domain 6: Defining rational use of thrombolytics. Journal of Veterinary Emergency and Critical Care. 2022;32(4):446-470. doi:10.1111/vec.13227

BibTeX
@article{Sharp2022,
  author = {Sharp, Claire R and Blais, Marie-Claude and Boyd, Corrin J and Brainard, Benjamin M and Chan, Daniel L and de Laforcade, Armelle and Goggs, Robert and Guillaumin, Julien and Lynch, Alex and Mays, Erin and McBride, Duana and Rosati, Tommaso and Rozanski, Elizabeth A},
  title = {2022 Update of the Consensus on the Rational Use of Antithrombotics and Thrombolytics in Veterinary Critical Care (CURATIVE) Domain 6: Defining rational use of thrombolytics},
  journal = {Journal of Veterinary Emergency and Critical Care},
  year = {2022},
  volume = {32},
  number = {4},
  pages = {446--470},
  doi = {10.1111/vec.13227}
}
Start for free →